DARE - Dare Bioscience, Inc.

QQQ $ 459.57 $ 0.43 (0.09 %)

DIA $ 406.95 $ -4.39 (-1.07 %)

SPY $ 548.21 $ -2.79 (-0.51 %)

TLT $ 99.11 $ -0.21 (-0.21 %)

GLD $ 231.64 $ -1.10 (-0.47 %)

Previous Close

$ 3.59

Open

$ 3.52

Bid

$ 3.51 x 100

Ask

$ 3.55 x 250

Day's Range

$ 3.52 - $ 3.52

52 Week Range

$ 3.05 - $ 8.40

Volume

78,720

Average Volume

Market Cap

30.68M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-28-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-30-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-31-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-27-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-14-2019	06-30-2019	10-Q
22	05-14-2019	03-31-2019	10-Q
23	04-01-2019	12-31-2018	10-K
24	11-13-2018	09-30-2018	10-Q
25	08-13-2018	06-30-2018	10-Q
26	05-14-2018	03-31-2018	10-Q
27	03-28-2018	12-31-2017	10-K
28	11-13-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-12-2017	03-31-2017	10-Q
31	03-31-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-02-2016	03-31-2016	10-Q
35	03-10-2016	12-31-2015	10-K
36	11-16-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-06-2015	03-31-2015	10-Q
39	03-19-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Daré Bioscience Announces Publication In T...
08/26/2024 12:13:33

Published data show that topical Sildenafil Cream, 3.6% was safe and well tolerated by women and their partners across 1,357 se...

Maxim Group Downgrades Dare Bioscience to ...
08/14/2024 16:21:57

Maxim Group analyst Caroline Palomeque downgrades Dare Bioscience (NASDAQ:DARE) from Buy to Hold.

Daré Bioscience Announces Publication In T...
08/13/2024 12:22:18

Published data show that responses from 1-month and 24-hour recall patient reported outcome (PRO) instruments were similar and ...

Dare Bioscience Q2 2024 GAAP EPS $1.52, Sa...
08/12/2024 20:31:59

Dare Bioscience (NASDAQ:DARE) reported quarterly earnings of $1.52 per share. The company reported $22.438 million in sales th...

Daré Bioscience Regains Compliance With Na...
07/19/2024 12:02:09

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in innovation for the health and wellbeing of women, announced that it was notif...

Trading Halt: Halt status updated at 8:55:...
07/01/2024 12:55:05

Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/28/2024 23:50:04

Daré Bioscience Announces 1-For-12 Reverse...
06/27/2024 12:11:58

Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- Daré Biosc...

Daré Bioscience Announces Publication Of P...
06/24/2024 12:01:07

Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (F...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
05/30/2024 16:31:20

why-james-hardie-industries-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why James Hardie Industries Shares Are Tra...
05/21/2024 17:36:28

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 16:31:03

bayer-highlights-detailed-data-from-twin-late-stage-trials-on-experimental-menopause-candidate-seeks-regulatory-approval

Bayer Highlights Detailed Data From Twin L...
05/17/2024 15:02:25

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe men...

HC Wainwright & Co. Reiterates Buy on Dare...
05/15/2024 14:43:49

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $6 price target.

Brookline Capital Upgrades Dare Bioscience...
05/15/2024 10:13:28

Brookline Capital analyst Kemp Dolliver upgrades Dare Bioscience (NASDAQ:DARE) from Hold to Buy and announces $3 price target.

Dare Bioscience Q1 EPS $(0.07) Misses $(0....
05/14/2024 12:27:31

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0...

Dare Bioscience Files For Common Stock Off...
05/10/2024 20:31:04

-SEC Filing

Daré Bioscience Selected As A Member Of AR...
05/02/2024 12:10:11

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it was selected as a spoke for ...

HC Wainwright & Co. Reiterates Buy on Dare...
05/01/2024 11:12:58

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $6 price target.

why-he-equipment-services-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why H&E Equipment Services Shares Are Trad...
04/30/2024 17:24:09